SKAN Group AG
SIX:SKAN
SKAN Group AG
SIX:SKAN
Price:
82.3 CHF
0.37%
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
SKAN
stock under the Base Case scenario is
128.85
CHF.
Compared to the current market price of 82.3 CHF,
SKAN Group AG
is
Undervalued by 36%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SKAN
Relative Value
Base Case
128.85
CHF
Undervaluation 36%
Valuation Multiples
Multiples Across Competitors
SKAN Competitors Multiples
SKAN Group AG Competitors
SKAN Group AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
SKAN Group AG
SIX:SKAN
|
1.8B CHF | 5.8 | 70.3 | 35.2 | 46.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 5.2 | 37 | 22.8 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
182.6B USD | 4.2 | 22.6 | 16.5 | 20.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.1B CHF | 5.7 | 58.2 | 20 | 29.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64.1 | 33.8 | 48.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7 | 33.8 | 23.6 | 26.3 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9 | 44.6 | 30.5 | 36.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.5 | 17.6 | 27.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
